Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
International Journal of Oncology
|
July 19, 2008
Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity
Roberta M Moretti, Marina Montagnani Marelli, Stefania Mai, et al.
Scientific Reports
|
October 31, 2019
Altered temporal sensitivity in obesity is linked to pro-inflammatory state
Federica Scarpina, Paolo Marzullo, Stefania Mai, et al.
Hormone Molecular Biology and Clinical Investigation
|
March 6, 2021
Circulating Inhibitory Factor 1 levels in adult patients with Prader-Willi syndrome
Maurizio Delvecchio, Graziano Grugni, Stefania Mai, et al.
Diagnostics (Basel, Switzerland)
|
October 23, 2021
Obesity and Bone Loss at Menopause: The Role of Sclerostin
Paolo Marzullo, Chiara Mele, Stefania Mai, et al.
International Journal of Oncology
|
December 5, 2006
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
International Journal of Oncology
|
May 17, 2011
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells
Roberta M Moretti, Stefania Mai, Marina Montagnani Marelli, et al.
Scientific Reports
|
June 11, 2017
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome
Chiara Mele, Graziano Grugni, Stefania Mai, et al.
Endocrine Reviews
|
July 11, 2012
GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies
Patrizia Limonta, Marina Montagnani Marelli, Stefania Mai, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 5, 2009
Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
Frontiers in Endocrinology
|
October 31, 2022
The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity
Chiara Mele, Stefania Mai, Tiziana Cena, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
International Journal of Oncology
|
July 19, 2008
Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity
Roberta M Moretti, Marina Montagnani Marelli, Stefania Mai, et al.
Scientific Reports
|
October 31, 2019
Altered temporal sensitivity in obesity is linked to pro-inflammatory state
Federica Scarpina, Paolo Marzullo, Stefania Mai, et al.
Hormone Molecular Biology and Clinical Investigation
|
March 6, 2021
Circulating Inhibitory Factor 1 levels in adult patients with Prader-Willi syndrome
Maurizio Delvecchio, Graziano Grugni, Stefania Mai, et al.
Diagnostics (Basel, Switzerland)
|
October 23, 2021
Obesity and Bone Loss at Menopause: The Role of Sclerostin
Paolo Marzullo, Chiara Mele, Stefania Mai, et al.
International Journal of Oncology
|
December 5, 2006
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
International Journal of Oncology
|
May 17, 2011
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells
Roberta M Moretti, Stefania Mai, Marina Montagnani Marelli, et al.
Scientific Reports
|
June 11, 2017
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome
Chiara Mele, Graziano Grugni, Stefania Mai, et al.
Endocrine Reviews
|
July 11, 2012
GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies
Patrizia Limonta, Marina Montagnani Marelli, Stefania Mai, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 5, 2009
Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
Frontiers in Endocrinology
|
October 31, 2022
The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity
Chiara Mele, Stefania Mai, Tiziana Cena, et al.
Page
of 4